- Home
- SGMO vs GGZ Comparison
SGMO vs GGZ Comparison
Compare SGMO & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- GGZ
- Stock Information
- Founded
- SGMO 1995
- GGZ 2013
- Country
- SGMO United States
- GGZ United States
- Employees
- SGMO N/A
- GGZ N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- GGZ Investment Managers
- Sector
- SGMO Health Care
- GGZ Finance
- Exchange
- SGMO Nasdaq
- GGZ Nasdaq
- Market Cap
- SGMO 122.8M
- GGZ 109.0M
- IPO Year
- SGMO 2000
- GGZ N/A
- Fundamental
- Price
- SGMO $0.51
- GGZ $14.33
- Analyst Decision
- SGMO Strong Buy
- GGZ
- Analyst Count
- SGMO 7
- GGZ 0
- Target Price
- SGMO $5.29
- GGZ N/A
- AVG Volume (30 Days)
- SGMO 5.2M
- GGZ 12.8K
- Earning Date
- SGMO 08-07-2025
- GGZ 01-01-0001
- Dividend Yield
- SGMO N/A
- GGZ 5.39%
- EPS Growth
- SGMO N/A
- GGZ N/A
- EPS
- SGMO N/A
- GGZ 1.75
- Revenue
- SGMO $81,706,000.00
- GGZ N/A
- Revenue This Year
- SGMO $21.24
- GGZ N/A
- Revenue Next Year
- SGMO N/A
- GGZ N/A
- P/E Ratio
- SGMO N/A
- GGZ $6.79
- Revenue Growth
- SGMO 565.52
- GGZ N/A
- 52 Week Low
- SGMO $0.41
- GGZ $9.43
- 52 Week High
- SGMO $3.18
- GGZ $12.50
- Technical
- Relative Strength Index (RSI)
- SGMO 44.92
- GGZ 62.91
- Support Level
- SGMO $0.47
- GGZ $14.17
- Resistance Level
- SGMO $0.56
- GGZ $14.64
- Average True Range (ATR)
- SGMO 0.03
- GGZ 0.22
- MACD
- SGMO -0.00
- GGZ -0.02
- Stochastic Oscillator
- SGMO 32.31
- GGZ 58.62
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.